SEC 13F Intelligence

Frazier Management LLC / SNDX

Frazier Management LLC’s Syndax Pharmaceuticals Inc Position

Does Frazier Management LLC own Syndax Pharmaceuticals Inc (SNDX)? Not currently — the last reported position was 2.77M shares worth $61M in Q4 2021; the fund’s latest 13F (Q3 2022) no longer reports it.

Position Value
$61M
Q4 2021
Shares
2.77M
% of Portfolio
+4.67%
Quarters Held
8
position exited

Position History SNDX

Reported value by quarter
Q1 ’20: $11MQ1 ’20Q2 ’20: $20MQ2 ’20Q3 ’20: $19MQ3 ’20Q4 ’20: $31MQ4 ’20Q1 ’21: $32MQ1 ’21Q2 ’21: $20MQ2 ’21Q3 ’21: $23MQ3 ’21Q4 ’21: $61MQ4 ’21filingsflow.com
QuarterSharesValue% of Portfolio
Q4 20212.77M$61M+4.67%
Q3 20211.19M$23M+1.82%
Q2 20211.19M$20M+1.88%
Q1 20211.44M$32M+2.57%
Q4 20201.41M$31M+2.41%
Q3 20201.32M$19M+1.75%
Q2 20201.32M$20M+1.72%
Q1 2020990.7K$11M+1.23%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Frazier Management LLC’s full portfolio or all institutional holders of SNDX.